Insulet
PODD
#1347
Rank
NZ$27.70 B
Marketcap
NZ$393.53
Share price
-0.16%
Change (1 day)
-12.39%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2025 (TTM): NZ$0.63 Billion

According to Insulet's latest financial reports the company's current earnings are NZ$2.52 Billion. In 2024 the company made an earning of NZ$0.58 Billion, an increase over its 2023 earnings that were of NZ$0.42 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$0.63 B7.64%
2024 NZ$0.58 B36.76%
2023 NZ$0.42 B481.9%
2022 NZ$73.7 M-45.24%
2021 NZ$0.13 B43.35%
2020 NZ$93.88 M18.51%
2019 NZ$79.22 M41.16%
2018 NZ$56.12 M-711.95%
2017 -NZ$9.18 Million-56.85%
2016 -NZ$21.26 Million-79.31%
2015 -NZ$0.11 Billion63.85%
2014 -NZ$62.72 Million31.04%
2013 -NZ$47.86 Million-21.96%
2012 -NZ$61.33 Million
2010 -NZ$58.49 Million-42.38%
2009 -NZ$0.11 Billion-33.56%
2008 -NZ$0.16 Billion65.93%
2007 -NZ$92.08 Million209.75%
2006 -NZ$29.73 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$55.40 B 8,807.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$13.91 B 2,137.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$10.96 B 1,662.44%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
NZ$38.48 B 6,087.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-NZ$0.36 Billion-156.35%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
NZ$0.21 B-65.57%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
NZ$1.67 B 168.90%๐Ÿ‡บ๐Ÿ‡ธ USA